Melody Cobleigh to Drug Evaluation
This is a "connection" page, showing publications Melody Cobleigh has written about Drug Evaluation.
Connection Strength
0.066
-
Phase II study of etoposide in previously untreated squamous cell carcinoma of the head and neck. Cancer Treat Rep. 1987 Mar; 71(3):321-2.
Score: 0.018
-
A phase II study of Adriamycin in previously untreated squamous cell carcinoma of the head and neck. Cancer. 1985 Dec 01; 56(11):2573-5.
Score: 0.017
-
Phase II study of vindesine in patients with metastatic breast cancer. Cancer Treat Rep. 1981 Jul-Aug; 65(7-8):659-63.
Score: 0.012
-
Phase II trial of fludarabine phosphate in advanced renal cell carcinoma: an Illinois Cancer Council Study. Invest New Drugs. 1989 Jul; 7(2-3):251-3.
Score: 0.005
-
Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council Study. Invest New Drugs. 1989 Jul; 7(2-3):223-4.
Score: 0.005
-
Phase II trial of aminothiadiazole in advanced non-small cell lung cancer. Cancer Treat Rep. 1986 Mar; 70(3):417-8.
Score: 0.004
-
Phase II trial of bisantrene for unresectable non-small cell bronchogenic carcinoma: an Illinois Cancer Council study. Cancer Treat Rep. 1983 Sep; 67(9):841-2.
Score: 0.004